sulfadiazine has been researched along with Hepatorenal Syndrome in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Hepatorenal Syndrome: Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The case of a patient who developed hepatorenal syndrome during treatment with sulfadiazine for toxoplasmosis retinitis is reported." | 7.77 | Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine. ( Khalili, H; Soudbakhsh, A; Talasaz, AH, 2011) |
| " The case of a patient who developed hepatorenal syndrome during treatment with sulfadiazine for toxoplasmosis retinitis is reported." | 3.77 | Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine. ( Khalili, H; Soudbakhsh, A; Talasaz, AH, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalili, H | 1 |
| Soudbakhsh, A | 1 |
| Talasaz, AH | 1 |
1 other study available for sulfadiazine and Hepatorenal Syndrome
| Article | Year |
|---|---|
Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine.
Topics: Antiprotozoal Agents; Female; Hepatorenal Syndrome; Humans; Liver; Outcome Assessment, Health Care; | 2011 |